Novartis FCPA Enforcement Action: Internal Controls
Tom Fox reviews the FCPA enforcement action involving Swiss pharmaceutical company Novartis, its Greek subsidiary, and Alcon Pte Ltd., which combined agreed to pay some $347 million in fines to resolve claims by the DOJ and SEC regarding FCPA violations.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.